Anti-cocaine vaccine development
- PMID: 20822352
- PMCID: PMC2936703
- DOI: 10.1586/erv.10.102
Anti-cocaine vaccine development
Abstract
Cocaine abuse is an ongoing and serious problem that has led to the growth of a brutal criminal enterprise, particularly in the Americas and Europe. At present, there are no effective pharmacological agents available to treat the addiction by blocking cocaine or reversing its effects. In order to help motivated addicts conquer their addiction, vaccines against cocaine are being developed and one has progressed to clinical trials. This article will discuss the concept of antidrug vaccines in general, the successes and limitations of the various anti-cocaine vaccine approaches, the results of the clinical trials with an anti-cocaine vaccine and some new vaccine-mediated approaches to combat cocaine addiction.
Figures
References
-
- Ruetsch YA, Boni T, Borgeat A. From cocaine to ropivacaine: the history of local anesthetic drugs. Curr Top Med Chem. 2001;1:175–182. - PubMed
-
- Wilson R. Drug abuse prevention: A school and community partnership. 3 ed. Jones & Bartlett; Sudbury, MA: 2010.
-
- The DASIS Report: Cocaine Route of Administration Trends: 1995-2005. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Rockville, MD: Sep 13, 2007. [online]. Available at: http://www.oas.samhsa.gov/2k7/crackTX/crackTX.htm.
-
- Preti A. New developments in the pharmacotherapy of cocaine abuse. Addict Biol. 2007;12:133–151. - PubMed
-
- Vocci FJ, Acri J, Elkashef A. Medication development for addictive disorders: the state of the science. Am J Psychiatry. 2005;162:1432–1440. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical